Europe Cell and Gene Therapy Market

Europe Cell and Gene Therapy Market Forecast to 2031 - Regional Analysis - by Type (Cell Therapy {Allogeneic, Autologous, and Viral Vectors}, and Gene Therapy {Non-viral Vectors, and Viral Vectors}), Services (Process Development, cGMP Manufacturing, Regulatory Services, and Bioassay Services), Scale (Pre-Commercial/R&D Manufacturing, and Commercial Scale Manufacturing), Service Providers (CDMOs and CMOs), and End User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, and Academic and Research Institutes)



Our Clients